Allan Vaag

35.2k total citations · 2 hit papers
419 papers, 20.7k citations indexed

About

Allan Vaag is a scholar working on Physiology, Pediatrics, Perinatology and Child Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Allan Vaag has authored 419 papers receiving a total of 20.7k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Physiology, 156 papers in Pediatrics, Perinatology and Child Health and 133 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Allan Vaag's work include Birth, Development, and Health (151 papers), Adipose Tissue and Metabolism (116 papers) and Diet and metabolism studies (87 papers). Allan Vaag is often cited by papers focused on Birth, Development, and Health (151 papers), Adipose Tissue and Metabolism (116 papers) and Diet and metabolism studies (87 papers). Allan Vaag collaborates with scholars based in Denmark, Sweden and United States. Allan Vaag's co-authors include Henning Beck‐Nielsen, Pernille Poulsen, Charlotte Brøns, Heidi Storgaard, Charlotte Ling, Claus M. Larsen, Leif Groop, Thomas Mandrup‐Poulsen, Marc Y. Donath and Mirjam Faulenbach and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Allan Vaag

411 papers receiving 20.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

2007 1.4k citations Allan Vaag et al. profile →
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

2009 688 citations Allan Vaag et al. Diabetologia profile →

Peers

Countries citing papers authored by Allan Vaag

Since Specialization

Citations

This map shows the geographic impact of Allan Vaag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Vaag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Vaag more than expected).

Fields of papers citing papers by Allan Vaag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Vaag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Vaag. The network helps show where Allan Vaag may publish in the future.

Co-authorship network of co-authors of Allan Vaag

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Vaag. A scholar is included among the top collaborators of Allan Vaag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Vaag. Allan Vaag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Physical Activity Health Paradox in Type 2 Diabetes 2025 ·American Journal of Preventive Medicine ·(unknown), Rasmus Wibæk, Pernille Falberg Rønn, (unknown), Charlotte Brøns, (unknown), Andreas Holtermann, Allan Vaag, Allan Linneberg, Mette Aadahl	2
2	1357-P: High Plasma Leptin Levels Are Associated with Low Birth Weight and Disease Severity in People with Recently Diagnosed Type 2 Diabetes 2024 ·Diabetes ·(unknown), (unknown), (unknown), Charlotte Brøns, Verena Hirschberg, Torben Hansen, Niels Jessen, Peter Vestergaard, Jens Steen Nielsen, Kurt Højlund, (unknown), Reimar W. Thomsen, Allan Vaag	1
3	Circulating triglycerides are associated with human adipose tissue DNA methylation of genes linked to metabolic disease 2023 ·Human Molecular Genetics ·Tina Rönn, Alexander Perfilyev, (unknown), Karl‐Fredrik Eriksson, Sine W. Jørgensen, Charlotte Brøns, Linn Gillberg, Allan Vaag, Elisabet Stener‐Victorin, Charlotte Ling	7
4	FOXO3A‐short is a novel regulator of non‐oxidative glucose metabolism associated with human longevity 2023 ·Aging Cell ·Evan E. Santo, Rasmus Ribel‐Madsen, Peter Stroeken, Vincent C. J. de Boer, Ninna S. Hansen, (unknown), Allan Vaag, Rogier Versteeg, Jihye Paik, Ellen M. Westerhout	8
5	Circulating Metabolomic and Lipidomic Signatures Identify a Type 2 Diabetes Risk Profile in Low-Birth-Weight Men with Non-Alcoholic Fatty Liver Disease 2023 ·Nutrients ·(unknown), (unknown), (unknown), Anne Cathrine B. Thuesen, Min Kim, Mina Ali, Else Rubæk Danielsen, Cristina Legido‐Quigley, Gerrit van Hall, Torben Hansen, Tarunveer S. Ahluwalia, Allan Vaag, Charlotte Brøns	2
6	Low birthweight is associated with a higher incidence of type 2 diabetes over two decades independent of adult BMI and genetic predisposition 2023 ·Diabetologia ·Rasmus Wibæk, Gregers S. Andersen, Allan Linneberg, Torben Hansen, Niels Grarup, Anne Cathrine B. Thuesen, (unknown), Jonathan C. K. Wells, Kasper Pilgaard, Charlotte Brøns, Dorte Vistisen, Allan Vaag	13
7	Cumulative Lactation and Clinical Metabolic Outcomes at Mid-Life among Women with a History of Gestational Diabetes 2022 ·Nutrients ·Pandora L. Wander, Stefanie N. Hinkle, Daniel A. Enquobahrie, Jing Wu, Sylvia H. Ley, Louise Groth Grunnet, Jorge E. Chavarro, Mengying Li, Anne Ahrendt Bjerregaard, Aiyi Liu, Peter Damm, Seth Sherman, Shristi Rawal, Yeyi Zhu, Liwei Chen, James L. Mills, Frank B. Hu, Allan Vaag, Sjúrđur F. Olsen, Cuilin Zhang	3
8	Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia 2020 ·PLoS ONE ·P. Mogensen, Kathrine Grell, Kjeld Schmiegelow, Ulrik Malthe Overgaard, Benjamin Ole Wolthers, Signe Sloth Mogensen, Allan Vaag, Thomas Leth Frandsen	11
9	Diabetes & Women’s Health (DWH) Study: an observational study of long-term health consequences of gestational diabetes, their determinants and underlying mechanisms in the USA and Denmark 2019 ·BMJ Open ·Cuilin Zhang, Sjúrđur F. Olsen, Stefanie N. Hinkle, Robert E. Gore‐Langton, Allan Vaag, Louise Groth Grunnet, Edwina Yeung, Wei Bao, Katherine Bowers, Aiyi Liu, James L. Mills, Seth Sherman, Audrey J. Gaskins, Sylvia H. Ley, (unknown), Jorge E. Chavarro, Frank B. Hu	31
10	Gestational Diabetes Mellitus and Renal Function: A Prospective Study With 9- to 16-Year Follow-up After Pregnancy 2018 ·Diabetes Care ·Shristi Rawal, Sjúrđur F. Olsen, Louise Groth Grunnet, Ronald C.W., Stefanie N. Hinkle, Charlotta Granström, Jing Wu, Edwina Yeung, James L. Mills, Yeyi Zhu, Wei Bao, Sylvia H. Ley, Frank B. Hu, Peter Damm, Allan Vaag, Michael Y. Tsai, Cuilin Zhang	38
11	Dnmt3a is an epigenetic mediator of adipose insulin resistance 2017 ·eLife ·(unknown), Emma Nilsson, Danielle Tenen, Anna Lyubetskaya, James C. Lo, (unknown), (unknown), Brian A. Dawes, Allan Vaag, Charlotte Ling, Evan D. Rosen, Sona Kang	98
12	Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial 2012 ·European Journal of Endocrinology ·Leo Niskanen, Lawrence A. Leiter, Edward Franek, Jianping Weng, Taner Damcı, Manuel Muñoz‐Torres, (unknown), Lars Endahl, Trine Vang Skjøth, Allan Vaag	47
13	Correction: The PNPLA3 rs738409 G-Allele Associates with Reduced Fasting Serum Triglyceride and Serum Cholesterol in Danes with Impaired Glucose Regulation 2012 ·PLoS ONE ·Nikolaj T. Krarup, Niels Grarup, Karina Banasik, Martin Friedrichsen, (unknown), Camilla H. Sandholt, (unknown), Pernille Poulsen, Daniel R. Witte, Allan Vaag, (unknown), Oluf Pedersen, Torben Hansen	3
14	LMNA rs4641 and the Muscle Lamin A and C Isoforms in Twins—Metabolic Implications and Transcriptional Regulation 2010 ·The Journal of Clinical Endocrinology & Metabolism ·Lise Wegner, (unknown), Jette Bork‐Jensen, Louise T. Dalgaard, Torben Hansen, Oluf Pedersen, Pernille Poulsen, Allan Vaag	10
15	Abstract 3226: Differences in Risk of Death according to Type of Oral Glucose-lowering Therapy in Patients with Diabetes: A Nationwide Study 2008 ·Circulation ·Tina Ken Schramm, Gunnar Gislason, (unknown), Søren Rasmussen, Casper H. Jørgensen, (unknown), Morten Lock Hansen, Emil Loldrup Fosbøl, Ditte‐Marie Bretler, Lars Køber, Allan Vaag, Christian Torp‐Pedersen	1
16	Glucose and Insulin Metabolism in Twins: Influence of Zygosity and Birth Weight 2001 ·Twin Research ·Pernille Poulsen, Allan Vaag	14
17	Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. 1994 ·Journal of Clinical Investigation ·Jan Erik Henriksen, F P Alford, Aase Handberg, Allan Vaag, G.M. Ward, (unknown), Henning Beck‐Nielsen	91
18	Impact of injection sites for soluble insulin on glycaemic control in Type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen 1993 ·Diabetologia ·Jan Erik Henriksen, M. S. Djurhuus, Allan Vaag, Peter Thye‐Rønn, (unknown), Ole Hother‐Nielsen, Henning Beck‐Nielsen	19
19	Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. 1991 ·Journal of Clinical Investigation ·Allan Vaag, P. Skøtt, P. Damsbo, M.-A. Gall, Erik A. Richter, Henning Beck‐Nielsen	108
20	NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue. 1989 ·BMJ ·Finn Stener Jørgensen, Allan Vaag, Lotte Langkjær, Philip Hougaard, Jan Markussen	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact